News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Features Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI? Michael O'Riordan December 02, 2020
News Features Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too Michael O'Riordan December 09, 2019
News Features Twitter Takes on the Times of India, but the Question Persists: Is Foregoing a Stent an Option? Shelley Wood April 30, 2019
News Features Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen? Michael O'Riordan September 13, 2017
News Features Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe Shelley Wood May 05, 2017
News Features The Numbers Game: Door-to-Balloon or First Medical Contact? STEMI Care Still Needs Work Nationwide L.A. McKeown March 16, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Features The Bioresorbable Stent Story So Far: What Promise? What Price? Michael O'Riordan August 17, 2016
News Features Las Sanciones de los CMS Impulsan los Intentos por Reducir las Rehospitalizaciones a los 30 Días July 21, 2015